Invenio completes enrolment in AI-based lung cancer imaging trial
Coming as part of a collaboration with pharmaceutical giant Johnson & Johnson, the multi-centre trial aims to test Invenio’s NIO...
Coming as part of a collaboration with pharmaceutical giant Johnson & Johnson, the multi-centre trial aims to test Invenio’s NIO...
The summer sun often shines down on children at play, but it can cause lifelong health risks for those kids...
AHRQ News Now is a weekly newsletter that highlights agency research and program activities.AHRQ StatsAccess more data on this topic...
You visit your primary care doctor every year for a checkup and schedule regular teeth cleanings with your dentist —...
Dr. Bradford GraySkin cancer is the most common cancer in the United States, with an estimated one in five Americans...
People living in the Inuit region of Nunavik in northern Quebec die earlier after a diagnosis of lung cancer than...
Add topic to email alerts Receive an email when new articles are posted on ...
A comprehensive digital tool within electronic health records leads to more patients receiving the recommended screenings for lung cancer, according...
A few years ago, Kim Lori Sandler, MD, realized many patients newly diagnosed with lung cancer had never been screened...